Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2024 Feb 2;19(2):e0293130. doi: 10.1371/journal.pone.0293130

Using the Theory of Planned Behavior to determine COVID-19 vaccination intentions and behavior among international and domestic college students in the United States

Cheng-Ching Liu 1,*,#, Jiying Ling 1,#, Nagwan R Zahry 2,, Charles Liu 3,, Ravichandran Ammigan 4,, Loveleen Kaur 1,5
Editor: Khalid Mehmood6
PMCID: PMC10836687  PMID: 38306348

Abstract

Vaccination is the most effective strategy for preventing infectious diseases such as COVID-19. College students are important targets for COVID-19 vaccines given this population’s lower intentions to be vaccinated; however, limited research has focused on international college students’ vaccination status. This study explored how psychosocial factors from the Theory of Planned Behavior (TPB; attitudes, perceived behavioral control, subjective norms, and behavioral intentions) related to students’ receipt of the full course of COVID-19 vaccines and their plans to receive a booster. Students were recruited via Amazon mTurk and the Office of the Registrar at a U.S. state university. We used binary logistic regression to examine associations between students’ psychosocial factors and full COVID-19 vaccination status. Hierarchical multiple regression was employed to evaluate relationships between these factors and students’ intentions to receive a booster. The majority of students in our sample (81% of international students and 55% of domestic students) received the complete vaccination series. Attitudes were significantly associated with all students’ full vaccination status, while perceived behavioral control was significantly associated with domestic students’ status. Students’ intentions to receive COVID-19 vaccines were significantly correlated with their intentions to receive a booster, with international students scoring higher on booster intentions. Among the combined college student population, attitudes, intentions to receive COVID-19 vaccines, and subjective norms were significantly related to students’ intentions to receive a booster. Findings support the TPB’s potential utility in evidence-based interventions to enhance college students’ COVID-19 vaccination rates. Implications for stakeholders and future research directions are discussed.

Introduction

The World Health Organization declared the coronavirus (COVID-19) outbreak a pandemic in March 2020. Almost seven million people worldwide and over one million Americans had lost their lives to the disease as of April 19, 2023 [1]. Vaccination remains the most effective means of mitigating and preventing infectious diseases such as COVID-19. Approximately 71% of the United States (U.S.) population aged 5 years and above are fully vaccinated against COVID-19, whereas less than 50% of the U.S. population aged 12 years and above have received their first booster [2]. COVID-19 vaccines help protect people from severe illness, hospitalization, and even death [3]. These vaccines also offer people who have had COVID-19 additional protection against hospitalization from a new infection. Receiving these vaccines can further contribute to community health via widespread immunization: vaccinated individuals indirectly protect the greater community by reducing person-to-person transmission. For example, once college students were sufficiently vaccinated against COVID-19, campuses began to resume in-person classes, large-group activities, sport programs, international exchanges, and social gatherings [4].

Many studies have been conducted on U.S. domestic college students’ acceptance, reluctance, risk perceptions, and attitudes regarding COVID-19 vaccines. The findings have been inconsistent [46]. For instance, Kecojevic et al. noted that about 45% of surveyed domestic college students found information about COVID-19 vaccines hard to understand, but 60% agreed that they were responsible for getting vaccinated and protecting others from the disease [4]. Between 6% and 8% of college students surveyed concurred that young adults do not need to receive COVID-19 vaccines thanks to natural immunity. On the contrary, researchers observed that 47.5% of sampled college students (n = 134) who had not yet been vaccinated were hesitant to receive COVID-19 vaccines [5]. In another study, researchers found that 50% of unvaccinated college students did not intend to receive these vaccines due to lack of trust in the vaccines’ efficacy, fear of side effects, and being suspicious of the U.S. government’s intentions behind the large push for vaccination [6].

Approximately 1.1 million international students enrolled at U.S. colleges in 2021, and in the 2022/23 academic year, these institutions expect to receive even more international student applications [7]. However, these students constitute an under-researched and vulnerable population, specifically in the health domain [8]. Only a handful of studies in the U.S. have examined international students’ vaccination status; of these, efforts have generally focused on human papillomavirus (HPV) vaccines. No research appears to have addressed international college students’ COVID-19 vaccination status in the U.S. Immunization schedules and vaccine availability differ nationally, potentially affecting international students at U.S. higher education institutions. Many of these students also lack access to preventive vaccines in their home countries [9]. According to the Our World in Data website (October 9, 2022), approximately 70% of the global population has received at least one COVID-19 vaccine versus only 23% of residents in low-income countries [10]. As an example, merely 17.5% of people in Nigeria are fully vaccinated against COVID-19 [10]. Although 90% of the Chinese population has been fully vaccinated with China’s CoronaVac and Sinopharm vaccines, scholars have questioned these immunizations’ length of protection given their poor efficacy in preventing symptomatic disease [10, 11]. Moore et al. indicated that international students enrolling at United Kingdom (U.K.) universities may need to be updated on domestic immunization policies due to differing vaccination schedules [12]. Specifically, the odds of U.K. nationals being vaccinated were about five times higher than for international (non-U.K.) students attending U.K. universities [12]. This discrepancy could reflect variation in immunization schedules between the U.K. and international students’ home countries. Moreover, researchers have determined that vaccine hesitancy is higher in some minority communities, such as the international student population [4]. These circumstances collectively call for further research. Current inconsistencies especially highlight the need to clarify college students’ attitudes towards and intentions to receive COVID-19 vaccines and boosters.

Barriers to vaccine hesitancy/refusal must be removed before effective health interventions and education about COVID-19 vaccines and boosters can be developed. Meanwhile, to increase immunization rates, it is essential to understand college students’ vaccination status and intentions to receive COVID-19 vaccines and boosters. Factors associated with COVID-19 vaccination also stand to be uncovered. This study examined whether psychosocial factors drawn from the Theory of Planned Behavior (TPB), namely attitudes, perceived behavioral control (PBC), subjective norms, and behavioral intentions were related to full COVID-19 vaccination and the intentions to receive a booster. We compared responses among domestic and international college students in the U.S. Students are considered fully vaccinated if at least 2 weeks have passed since receipt of either the first Johnson & Johnson shot or the second Pfizer or Moderna shot [13].

Theoretical framework

The TPB is a robust model that is predictive of human actions in specific contexts [14]. We adopted this theory to investigate whether attitudes, PBC, subjective norms, and behavioral intentions were associated with full COVID-19 vaccination and the intentions to receive a booster among international and domestic college students in the U.S. Attitudes refer to one’s perceptions of a behavior as either favorable or unfavorable. PBC captures the extent to which a person believes they can execute a behavior. Subjective norms reflect social pressure to perform a behavior [14]. According to TPB, individuals’ attitudes, PBC, and subjective norms can influence their intentions to engage in a behavior, which can lead to performing the behavior [14]. Researchers have applied the TPB to predict individuals’ intentions and engagement in receiving vaccination against influenza, HPV, and COVID-19 [1517]. For example, a recent meta-analysis of 43 articles found that TPB constructs including attitudes, PBC, and subjective norms predicted intentions to receive a COVID-19 vaccine among adult general population, parents, and patients [17]. Based on TPB, in our study, individuals’ positive attitudes (e.g., “I believe that the COVID-19 vaccine[s] is effective”), PBC (e.g., “I have the time to get the COVID-19 vaccine[s]”), and subjective norms (e.g., “My family thinks I should get the COVID-19 vaccine[s]”) were hypothesized to be associated with greater intentions to engage in COVID-19 vaccination. Moreover, greater intentions were assumed to be related to receiving a COVID-19 vaccine.

Methods

Research design and participant recruitment

This study was reviewed and classified as exempt by the hosting university’s Institutional Review Board. This study involved a nonexperimental, cross-sectional design. The primary sample comprised college students between 18 and 26 years old. Two groups (i.e., domestic and international students) were nonrandomly selected to complete an online survey. Domestic students enrolled at U.S. higher education institutions were surveyed via Amazon Mechanical Turk (mTurk). International students were recruited from a large state university in the midwestern U.S. The university’s Registrar Office sent out an email to all international students to complete a Qualtrics survey. In the email containing a link to the questionnaire, recipients were informed that the study concerned COVID-19 vaccines and boosters. Students were not required to provide their written informed consent to participate in this study; however, students were required to read the consent information and check a box in the Qualtrics survey to certify that they agreed to participate in the study. Without checking the box, students would not be able to see and answer any questions. Students were also told that they could exit the survey at any time. All data was obtained anonymously.

Using the G*Power program, we assumed a small effect size with an odds ratio (OR) of 1.68 [18], 50% probability of not being fully vaccinated [2] and a significance level of 0.05, a sample size of 133 was needed to achieve at least an 80% study power when using logistic regression models to examine factors related to the full COVID-19 vaccination status. With a predicted 15% missing data rate, we over sampled to obtain at least 157 participants in each group. This sample size was also adequate for achieving a minimum of 80% study power when using hierarchical linear regression models to examine 17 variables that might be associated with intentions to receive a COVID-19 booster.

Measures

Study measures were adapted from the TPB-based instrument developed by Catalano and colleagues [16]. The original version was developed to assess attitudes, PBC, subjective norms, and behavioral intentions in the context of HPV vaccination among college students [16]. The original instrument demonstrated acceptable readability for college students, good face and content validity via an expert panel review, acceptable test-retest reliability, and great internal consistency reliability with Cronbach’s alphas ranging from 0.92 to 0.97 [16]. In addition, the original instrument had good construct validity through factor loadings of four constructs and acceptable predictive validity explaining 58% of the variance in intentions to receive HPV vaccine [16]. We adapted this instrument by replacing ‘HPV vaccine’ with ‘COVID-19 vaccine,’ while maintaining the same question items, to measure attitudes, PBC, subjective norms, and behavioral intentions in relation to receiving COVID-19 vaccines and boosters.

Respondents’ demographic information (e.g., age, sex, ethnicity, education, health status, smoking history, other vaccination status) was also collected. For health status, participants were asked to answer if they were currently diagnosed with any diseases including diabetes, hypertension, autoimmune disease, hepatitis asthma, and cardiac disease; had a chronic medical condition requiring medication or regular physician visits; or had overall very good health with no disease. For smoking status, participants were asked to identify if they smoked, never smoked, or used to smoke but quit. Participants were also asked to identify if they had received one dose of the COVID-19 vaccine, they were fully vaccinated including one dose of Johnson & Johnson or two doses of Pfizer/Moderna, they had already received a booster shot, or they never received any COVID-19 vaccines. For general vaccination, participants were asked to indicate how up-to-date they were on vaccinations, with responses including: currently up-to-date, no but planning to be updated, or no and not planning to be updated.

Attitudes towards behavior receiving all COVID-19 vaccines and boosters were defined as a respondent’s view of doing so as either favorable or unfavorable. Attitudes towards receiving all COVID-19 vaccines and boosters in the next 12 months were measured using seven items based on bipolar adjectives and scored on a 7-point Likert-type scale (e.g., “I think getting the COVID-19 vaccines and booster in the next 12 months would be…”; 1 = not at all protective, 7 = extremely protective). There are 7 questions in this subscale and the possible sum scores ranged from 7 to 49 (See Table 2).

Table 2. TPB model items, factor loadings, and average variance extracted (AVE).

TPB constructs and corresponding items Factor Loadings AVE
Attitudes toward behavior 60.1%
1. I think getting all doses of the COVID-19 vaccines in the next 12 months would be
Very Bad ~ Very Good
0.77
2. I think getting all doses of the COVID-19 vaccines in the next 12 months would be
Not at all protective ~ Extremely Pprotective
0.76
3. I think getting all doses of the COVID-19 vaccines in the next 12 months would be
Unnecessary ~ Necessary
0.75
4. I think getting all doses of the COVID-19 vaccines in the next 12 months would be
Very unhealthy ~ Very healthy
0.77
5. I think getting all doses of the COVID-19 vaccines in the next 12 months would be
Disadvantageous ~ Advantageous
0.86
6. I think getting all doses of the COVID-19 vaccines in the next 12 months would be
Painful ~ Painless
0.69
7. I think getting all doses of the COVID-19 vaccines in the next 12 months would be
Extremely harmful ~ Extremely beneficial
0.78
Perceived Behavioral Control 54.7%
1. If I wanted to, I am sure I could get all doses of the COVID-19 vaccines in the next 12 months. Completely unsure ~ Completely sure 0.76
2. For me to get all doses of the COVID-19 vaccines in the next 12 months would be Extremely difficult ~ Extremely easy 0.77
3. How much control do you have to get all doses of the COVID-19 vaccine in the next 12 months? No control ~ Completely control 0.73
4. I am confident I can get all doses of the COVID-19 vaccines in the next 12 months, even if there is a financial cost. Very unconfident ~ Very confident 0.72
5. I am confident I can get all doses of the COVID-19 vaccines in the next 12 months, even if my schedule is busy. Very unconfident ~ Very confident 0.69
6. I am confident I can find a healthcare provider (for example, clinic, health center, physician’s office) where I can get all doses of the COVID-19 vaccines in the next 12 months. Very unconfident ~ Very confident 0.73
Subjective Norms 60.8%
1. Most people who are important to me think that I should get all doses of the COVID-19 vaccines in the next 12 months. Completely disagree ~ Completely agree 0.72
2. My parent(s) or legal guardian(s) would like me to get all doses of the COVID-19 vaccines in the next 12 months. Completely disagree ~ Completely agree 0.79
3. Family members other than my parent(s) or legal guardian(s) (for example, sibling, aunt, uncle, grandparent, etc.) would like me to get all doses of the COVID-19 vaccines in the next 12 months. Completely disagree ~ Completely agree 0.87
4. My friends would like me to get all doses of the COVID-19 vaccines in the next 12 months. Completely disagree ~ Completely agree 0.71
Behavioral Intentions 87.7%
1. I intend to get all doses of the COVID-19 vaccines in the next 12 months. Completely disagree ~ Completely agree 0.93
2. I will try to get all doses of the COVID-19 vaccines in the next 12 months. Completely disagree ~ Completely agree 0.93
3. I plan to get all doses of the COVID-19 vaccines in the next 12 months—Completely disagree ~ Completely agree. 0.93

PBC referred to the extent to which a respondent believed they could control receiving all COVID-19 vaccines and a booster in the next 12 months. This subscale included six items based on bipolar adjectives and scored on a 7-point Likert-type scale (e.g., “For me to get all COVID-19 vaccines and booster in the next 12 months would be…”; 1 = extremely difficult, 7 = extremely easy). There are 6 questions in this subscale and the possible sum scores ranged from 6 to 42.

Subjective norms were operationalized as one’s general belief that significant people in their lives (e.g., family members or close friends) thought they should or should not get COVID-19 vaccines and a booster in the next 12 months. This subscale contained four items scored on a 7-point Likert-type scale (e.g., “My parents or legal guardians would like me to get the COVID-19 vaccines and booster in the next 12 months”; 1 = completely disagree, 7 = completely agree). There are 4 questions in this subscale and the possible sum scores ranged from 4 to 28.

Behavioral intentions reflected college students’ intentions to receive all COVID-19 vaccines and a booster in the next 12 months. This subscale featured three items scored on a 7-point semantic differential scale (e.g., “I plan to get all COVID-19 vaccines and booster in the next 12 months”; 1 = completely disagree, 7 = completely agree). There are 3 questions in this subscale and the possible sum scores ranged from 3 to 21, with higher scores indicating greater willingness to receive COVID-19 vaccines and boosters.

Data analysis

All analyses were performed in SPSS for Windows v28.0 (SPSS Inc., Chicago, IL, USA). Descriptive statistics returned counts and frequencies for categorical data and means and standard deviations for continuous data. Chi-square tests or independent t tests based on the focal variables’ characteristics, were performed to determine variable-based differences between domestic and international students. Construct validity of the TBP-based instrument was assessed employing Principal Components with varimax rotation analysis. The numbers of factors were determined by Kaiser–Meyer–Olkin (KMO), scree plots, loadings of over .40, and explainable percentages of variance [19]. Cronbach’s alpha was used to estimate the internal consistency reliability. Binary logistic regression was used to examine associations between TPB-based psychosocial factors (attitudes, PBC, subjective norms, behavioral intentions) and full COVID-19 vaccination status. Covariates such as respondents’ age, sex, ethnicity/race, smoking behavior, chronic illnesses, health insurance, and vaccination history (including influenza) were also included in our model. All covariates were dummy coded except age. The four TPB factors were analyzed as continuous variables. Hierarchical multiple linear regression was conducted to evaluate the relationships of attitudes, PBC, subjective norms, and intentions to receive COVID-19 vaccines with intentions to receive a COVID-19 booster. For the hierarchical multiple linear regression model, demographic variables (i.e., age, sex, ethnicity/race, financial status, smoking behavior, chronic illnesses, health insurance, and vaccination history) were entered in Block 1; intentions to receive COVID-19 vaccines, attitudes towards receiving these vaccines, subjective norms, and PBC were entered in Block 2. Results were considered statistically significant at p < 0.05. Missing data were controlled by using group averages if participants missed answering 1 or 2 questions. If participants missed answering more than 3 questions, that participant was excluded from analysis.

Results

Participant characteristics

The sample included 197 international and 222 domestic college students. International students’ mean age was 20.27 years (±2.75). About 44% were women (n = 86), 37% were freshmen (n = 73), 85% (n = 167) indicated they never smoked, 75% were up to date on general vaccines including influenza (n = 147), 70% were Asian (n = 137), 81% were fully vaccinated against COVID-19 (n = 160), and 4% (n = 8) had received a COVID-19 booster. Domestic students’ mean age was 24.62 years (±3.38); half were women (n = 110), 27% (n = 59) indicated that they smoked, 78% were up to date on other vaccines including influenza (n = 172), 77% were white (n = 171), 55% were fully vaccinated against COVID-19 (n = 121), and none had received a booster. As listed in Table 1, these student groups varied significantly in age, ethnicity, health status, smoking status, health insurance, marital status, and COVID-19 vaccination status. Domestic students were older than international students. Most domestic students were white (n = 171, 77%) whereas most international students were Asian (n = 137, 69.5%). More international students (n = 160, 81.2%) were fully vaccinated against COVID-19 compared with domestic students (n = 121, 54.5%). More domestic students (n = 108, 49%) than international students (n = 9, 4.5%) reported having chronic illnesses. For instance, 36 domestic students (16.6%) had been diagnosed with hypertension, 26 (12%) had diabetes, 19 (8.8%) had an autoimmune disease, and 16 (7.4%) had asthma.

Table 1. Demographics.

Variable International Students (n = 197) Domestic Students (n = 222) Total (N = 419) p
Age 20.27±2.75 24.62±3.38 22.53±3.91 < .001*
Sex
Male
Female

110 (55.8%)
86 (43.7%)

112 (50.5%)
110 (49.5%)

222 (53%)
196 (47%)
.386
Ethnicity
Caucasian
Asian
Hispanic
Black/African American
American Indian

24 (12.2%)
137 (69.5%)
15 (7.6%)
10 (5.1%)
0

171 (77%)
27 (12.2%)
8 (3.6%)
7 (3.2%)
7 (3.2%)

195 (46.5%)
164 (39%)
23 (5.4%)
27 (6.4%)
7 (1.6%)
< .001*
Health status
Diabetes
Hypertension
Autoimmune disease
Hepatitis
Asthma
Cardiac disease
Other chronic conditions
Healthy overall

1 (.5%)
1 (.5%)
2 (1%)
0
3 (1.5%)
0
3 (1.5%)
75 (88.8%)

26 (11.7%)
36 (16.2%)
19 (8.6%)
6 (2.7%)
16 (7.2%)
2 (1%)
3 (1.4%)
109 (49.1%)

27 (6.4%)
37 (8.8%)
21 (5%)
6 (1.4%)
19 (4.5%)
2 (.5%)
6 (1.4%)
284 (67.8%)
< .001*
Smoking status
Yes
No, never
Past smoker

15 (7.6%)
167 (84.8%)
8 (4.1%)

59 (26.6%)
145 (65.3%)
13 (5.9%)

74 (17.7%)
312 (74.5%)
21 (5%)
.010*
Currently up to date on vaccinations 147 (74.6%) 172 (77.5%) 319 (76%) .783
Have health insurance 186 (94.4%) 170 (76.6%) < .001*
School
Agriculture
Arts & Letters
Business
Communication Arts
Education
Engineering
Human Medicine
Law
Music
Natural Science
Nursing
Osteopathic Medicine
Social Science
Other

5 (2.5%)
0
36 (18.3%)
15 (7.6%)
6 (3%)
62 (31.5%)
2 (1%)
2 (1%)
2 (1%)
28 (14.2%)
1 (.5%)
2 (1%)
23 (11.7%)
9 (4.6%)

4 (1.8%)
22 (9.9%)
30 (13.5%)
22 (9.9%)
30 (13.5%)
67 (30.2%)
11 (5%)
2 (1%)
2 (1%)
7 (3.2%)
1 (.5%)
2 (1%)
14 (6.3%)
6 (2.7%)

9 (2%)
22 (5%)
66 (16%)
37 (8.8%)
36 (8.6%)
129 (31%)
13 (3%)
4 (1%)
4 (1%)
35 (8.4%)
2 (.5%)
4 (1%)
37 (8.8%)
15 (3.6%)
< .001*
College year
Freshman
Sophomore
Junior
Senior

73 (37.1%)
33 (16.8%)
49 (24.9%)
38 (19.3%)

24 (10.8%)
32 (14.4%)
72 (32.4%)
92 (41.4%)

97 (23%)
65 (16%)
121 (29%)
130 (31%)
< .001*
Marital status
Married/living with partner
Divorced/separated
Single
In a relationship

5 (2.5%)
1 (.5%)
150 (76.1%)
38 (19.3%)

90 (40.5%)
0
100 (49.1%)
23 (10.4%)

95 (22.7%)
1 (.2%)
259 (61.8%)
61 (14.6%)
< .001*

Note.

*Results were statistically significant.

TBP instrument reliability and validity

Construct validity

Results from the factor analysis support the good construct validity of the adapted instrument. The KMO was 0.91 indicating sampling adequacy [20]. Bartlett’s test of sphericity was statistically significant (p < .001). Four factors were extracted and explained 69.35% of the total variance in Table 2.

Internal consistency reliability

Cronbach’s alpha was employed to assess internal consistency in this study. The Cronbach’s alpha for attitudes toward behavior subscale was .93 among international students and .89 among domestic students. For the PBC subscale, it was .85 for international students and .86 for domestic students. The Cronbach’s alpha for subjective norms subscale was .94 for international students and .82 for domestic students. For the behavioral intentions subscale, Cronbach’s alpha was .98 for international students and .92 for domestic students.

TBP-based psychosocial factors

As demonstrated in Table 3, international students scored higher on attitudes towards receiving COVID-19 vaccines, subjective norms, and intentions to receive these vaccines but not on PBC. Similarly, international students had more positive attitudes and stronger intentions to receive a COVID-19 booster than domestic students. A statistically significant difference manifested between international and domestic students’ attitudes towards receiving COVID-19 vaccines and boosters as well as intentions to receive these immunizations. No statistically significant differences emerged between these student groups in terms of subjective norms or PBC.

Table 3. Comparisons between domestic and international students.

Variable International Students
Mean ± SD
Domestic Students
Mean ± SD
χ2/t statistic p
COVID-19 vaccine(s)
Haven’t received any
Received 1 dose
Fully vaccinated
Received booster

6 (3%)
23 (11.7%)
160 (81.2%)
8 (4.1%)

13 (5.9%)
88 (39.6%)
121 (54.5%)
0
77.644 < .001*
Intentions to receive COVID-19 vaccine 16.54±5.26 14.27±5.02 20.232 < .001*
Intentions to receive COVID-19 booster 16.78±5.13 14.9±4.84 14.719 < .001*
Attitudes towards COVID-19 vaccine 42.11±7.61 39.27±7.39 14.999 < .001*
Attitudes towards COVID-19 booster 40.51±8.82 38.58±7.54 5.800 .016*
Subjective norms 22.24±5.65 21.77±4.26 .931 .335
PBC 32.09±6.58 32.62±5.86 .773 .380

Note.

*Results were statistically significant; PBC: perceived behavioral control. For definitions of COVID-19 vaccines, please refer to Measures.

TPB-based factors and receiving full COVID-19 vaccines

Table 4 presents the results of binary logistic regression, taking full COVID-19 vaccination as a categorical variable (i.e., either fully vaccinated or not). Domestic students who were male (OR = .31, 95% CI: .16-.63; p ≤ .001) had lower odds of being fully vaccinated, consistent with our findings when combining both student groups (OR = .60, 95% CI: .38-.95; p = .029). Domestic students who had higher PBC (OR = 1.10, 95% CI: 1.02–1.18; p = .016) had higher odds of being fully vaccinated, similar as the results among all students (OR = 1.08, 95% CI: 1.04, 1.13; p < .001). International students who had higher scores on attitudes had higher odds of being fully vaccinated (OR = 1.07, 95% CI: 1.00–1.15; p = .049); however, international students who had higher intentions had lower odds of being fully vaccinated (OR = .88, 95% CI: .77–1.00; p = .042). Among all students, those who were older (OR = .87, 95% CI: .81-.94; p ≤ .001) and smoking (OR = .48, 95% CI: .26-.89; p = .019) demonstrated lower odds of being fully vaccinated against COVID-19.

Table 4. TBP-based factors of fully receiving COVID-19 vaccines.

International Students Domestic Students All Students
Factors OR 95% CI p OR 95% CI p OR 95% CI p
Age .88 .76, 1.03 .102 .96 .86, 1.07 .430 .87 .81, .94 < .001 *
Sex (male) 1.70 .78, 3.72 .186 .31 .16, .63 < .001 * .60 .38, .95 .029 *
Ethnicity (Hispanic) .55 .12, 2.53 .441 2.35 .44, 12.43 .315 1.13 .40, 3.15 .821
Race (Asian) .72 .27, 1.92 .514 .32 .08, 1.35 .121 1.43 .85, 2.42 .182
Chronic illness (yes) 1.05 .19, 5.69 .956 .87 .44, 1.71 .683 .58 .34, 1.01 .056
Updated vaccination (yes) 1.68 .70, 4.01 .247 2.19 .91, 5.28 .079 1.73 .99, 3.03 .056
Smoking (yes) .56 .16, 2.01 .373 .59 .27, 1.29 .185 .48 .26, .89 .019 *
Health insurance (yes) 7.66 .44, 132.81 .162 .50 .21, 1.20 .123 1.22 .61, 2.44 .583
Attitudes 1.07 1.00, 1.15 .049 * 1.06 .99, 1.13 .121 1.08 1.04, 1.13 < .001 *
Behavioral intentions .88 .77, 1.0 .042 * .97 . 90, 1.05 .455 .97 .92, 1.03 .326
PBC .99 .92, 1.06 .678 1.10 1.02, 1.18 .016 * 1.02 .98, 1.06 .419
Subjective norms 1.03 .93, 1.14 .528 .99 .88, 1.10 .814 .96 .90, 1.03 .256

Note.

*Results were statistically significant; CI: confidence interval; PBC: perceived behavioral control. For definitions of chronic illness (health status), updated vaccination, and smoking status, please refer to Measures.

TPB-based factors and intentions to receive a COVID-19 booster

Results of the hierarchical multiple regression are summarized in Table 5. In the first step of analysis (Block 1), demographics (i.e., ethnicity/race, sex, age, college year, smoking status, health insurance, chronic illnesses, financial status, and vaccination history) explained only 8.4% of the variance in all students’ intentions to receive a COVID-19 booster. Having chronic illnesses (B = 1.26, p = .038) increased students’ intentions to do so whereas being male (B = -1.27, p = .012) decreased it. In the second step (Block 2), demographics, attitudes, subjective norms, PBC, and intentions to receive COVID-19 vaccines explained 68% of the variance in intentions to receive a booster. Students’ intentions to receive COVID-19 vaccines (B = .61, p < .001), attitudes towards receiving these vaccines (B = .07, p = .004), and subjective norms (B = .13, p < .001) were significantly related to their intentions to receive a booster.

Table 5. TBP-based factors of intentions to receive a COVID-19 booster.

International Students
Block 1: R2 = .08
Domestic Students
Block 1: R2 = .15
Combined Group
Block 1: R2 = .08
Factors Β (95% CI) p Β (95% CI) p Β (95% CI) p
Age (18–22) 1.72 (-.87, 4.31) .192 .69 (-1.04, 2.42) .432 .27 (-.96, 1.51) .662
Sex (male) -.84 (-2.32, .64) .265 -.64 (-2.14, .86) .402 -1.27 (-2.27, -.27) .012 *
Asian (Other) .64 (-2.98, 4.26) .728 -1.38 (-5.18, 2.42) .476 .12 (-2.43, 2.68) .924
White (Other) -.2.16 (-4.25, 3.82) .916 -.90 (-4.35, 2.53) .603 -.89 (-3.49, 1.70) .498
Black (Other) -2.29 (-7.09, 2.51) .347 .68 (-4.09, 5.47) .777 -1.05 (-4.41, 2.30) .538
Hispanic (Other) 2.81 (-1.56, 7.20) .206 -1.35 (-5.97, 3.27) .565 1.02 (-2.14, 4.18) .527
Chronic illness (Healthy) -.53 (-3.17, 2.10) .690 1.34 (-.02, 2.70) .054 1.26 (.07, 2.46) .038 *
Updated vaccination (Updated) -.03 (-1.68, 1.61) .967 1.65 (-.03, 3.34) .055 .87 (-.30, 2.05) .147
Smoking (Smoker) -.66 (-3.38, 2.06) .633 1.64 (.10, 3.18) .037 * .67 (-.65, 1.99) .318
Received COVID-19 vaccine -.89 (-2.56, .76) .289 1.48 (.10, 2.85) .035 * .85 (-.15, 1.86) .097
Financial status (Scholarship) .62 (-.94, 2.19) .434 -1.41 (-2.97, .14) .075 -.004 (-1.06, 1.05) .995
Parent education (< college) -1.11 (-2.69, .45) .162 .55 (-.92, 2.04) .459 -.18 (-1.24, .87) .730
Health insurance 1.29 (-2.92, 5.51) .545 .55 (-1.03, 2.15) .049 * 1.35 (-.09, 2.80) .095
Block 2: R2 = .65 Block 2: R2 = .72 Block 2: R2 = .68
Attitudes .09 (.02, .16) .141 .05 (-.02, .13) .153 .07 (.02, .12) .004 *
Behavioral intentions .53 (.43, .64) < .001 * .64 (.56, .73) < .001 * .61 (.55, .68) < .001 *
PBC .05 (-.02, .13) .163 .05 (-.02, .13) .203 .04 (-.01, .10) .071
Subjective norms .18 (.06, .29) .002 * .10 (-.01, .23) .096 .13 (.05, .21) < .001 *

Note.

*Results were statistically significant; CI: confidence interval; PBC: perceived behavioral control.

Upon comparing both student groups, no demographic variables were significantly correlated with international students’ intentions to receive a COVID-19 booster, while smoking (B = 1.64, p = .037) was significantly related to domestic students’ intentions to do so. The model containing demographics, attitudes, subjective norms, PBC, and intentions to receive COVID-19 vaccines explained 65% of the variance in international students’ intentions to receive a booster and 72% of that for domestic students. International students’ intentions to receive COVID-19 vaccines (B = .53, p < .001) and subjective norms (B = .18, p = .002) were significantly related to their intentions to receive a booster. Only domestic students’ intentions to receive COVID-19 vaccines (B = .64, p < .001) were significantly correlated with their intentions to receive a booster.

Discussion

This study examined whether TPB-based factors (i.e., attitudes, PBC, subjective norms, and behavioral intentions) were related to college students’ full COVID-19 vaccination status and intentions to receive a COVID-19 booster among domestic and international college students in the U.S. Even though not all TPB-based factors were statistically significantly related to college students’ full COVID-19 vaccination status or intentions to receive a COVID-19 booster, the TPB-based factors together explained about 65% of the variance in intentions to receive a COVID-19 booster. Therefore, our results support the utility of TBP in explaining college students’ COVID-19 vaccination intentions and behavior, and some variations were observed between domestic and international students.

Another potential explanation for the difference is that the higher rates of having chronic illnesses (e.g., hypertension, diabetes, autoimmune diseases, and asthma) among domestic students might have contributed to their vaccination hesitancy due to fear of side effects. This explanation is further supported by prior literature. For example, Vallée indicated that 28.7% of French people with HIV were hesitant to receive COVID-19 vaccines due to concerns about their overall health, chronic disease status, and vaccine-related side effects [21]. Rakusa discovered that people with multiple sclerosis and other autoimmune disorders were reluctant to be vaccinated against COVID-19 out of fear of side effects and potentially worsening neurological status [22]. However, based on guidelines from the Centers for Disease Control and Prevention (CDC), people with certain chronic illnesses (e.g., diabetes, cancer, heart disease, lung disease, or immune system disease) should consider receiving COVID-19 vaccines because these immunizations can best protect them from serious illness or death from the virus [23]. More efforts are therefore needed to reduce misinformation about the relationship between chronic conditions and COVID-19 vaccines, especially among U.S. domestic students.

COVID-19 vaccination differences between domestic and international students

Surprisingly, international students’ COVID-19 vaccination rates were significantly higher than for domestic students. Government policies may have informed this difference: as of November 8, 2021, international students holding an F-1 or J-1 nonimmigrant student visa (i.e., not U.S. citizens) were required to show proof of full vaccination before flying to the U.S. [24, 25]. This standard did not apply to U.S. citizens, U.S. nationals, U.S. lawful permanent residents, immigrants, or (under certain circumstances) air crew members [24]. Most states also required colleges to accommodate domestic students exempted from vaccination for medical or religious reasons.

TPB-based factors and receiving full COVID-19 vaccines

This study found that being male had lower odds of being fully vaccinated. COVID-19 is more likely to kill men than women in the U.S., yet many men in this country are not overly eager to be vaccinated [26, 27]. Slightly more than three-quarters (76.1%) of women aged 18 and above were fully vaccinated against COVID-19 compared with 71.5% of men between August 29 and October 30, 2021 [27]. Women may be more inclined than men to be proactive about public health issues and to pursue preventive health care. This outcome counters the results of a systematic review published in 2022 that analyzed data from 46 studies (141,550 participants): in 58% of cases, men had higher intentions than women to receive COVID-19 vaccines [28]. Zhong also pointed out that men held more positive attitudes and subjective norms than women regarding the importance of COVID-19 vaccination [29].

Unexpectedly, smokers had lower odds of being fully vaccinated, although research reported that smoking was associated with a higher risk of COVID-19 infection and with greater risks of all outcomes and hospitalization [30]. Similarly, patients who smoked more than 30 pack-years had 2.25 times higher odds of being hospitalized and were 1.89 times more likely to die after a COVID-19 diagnosis compared with people who had never smoked [31]. Although not statistically significant, our results indicate that college students with chronic illnesses had lower odds of being fully vaccinated compared to those without chronic illnesses. As we discussed earlier, individuals with chronic illnesses are hesitate of receiving COVID-19 vaccines due to the fear of side effects. Smokers and people with chronic diseases represent priority groups for COVID-19 vaccination, so programs focusing on reducing misinformation especially about the relationship between chronic illnesses and vaccines are needed to improve the vaccination rate.

Our study found that college students who were older had lower odds of being fully vaccinated which contrasts with two other studies that found higher vaccination rates among older adults compared with younger adults [32, 33]. However, our finding is consistent with a CDC report showing that college-aged young adults who were 25 or older were less likely than those aged 18 to 24 to get COVID-19 vaccines [34]. Additionally, a study investigated seasonal influenza vaccination coverage from four thousand college students in North Carolina found that being a freshman was related to the receipt of influenza vaccine because they were usually required to live on campus and were frequently receiving university announcements about the availability of vaccines and other resources [35]. Therefore, college campus efforts are needed to focus on older college students to improve their accessibility to vaccines.

In this study, PBC was the sole TPB-based factor that was significantly related to vaccination against COVID-19 in domestic students. According to Ajzen, PBC is a joining concept that combined perceived control (i.e., the level of control an individual has over gotten vaccinated) with self-efficacy (i.e., people’s confidence in their ability to vaccinate [36]). Our finding showed that college students with higher PBC had higher odds of being fully vaccinated which is consistent with some prior studies [3639]. For example, Hayashi et al. reported that PBC was the most robust factor of TPB in their study that predicted American adults’ intentions to take a COVID-19 vaccine [38]. Moreover, research showed that PBC was a very strong predictor to the intentions of people living with HIV to receive the COVID-19 vaccination [39]. Thus, programs targeting domestic college students’ PBC may be very promising in improving their vaccine uptake.

Positive attitudes were significantly related to full vaccination against COVID-19 in international and all student groups. Researchers pointed out that individuals with more positive attitudes were more willing to receive vaccines [40]. However, a prior study showed that individuals with positive attitudes toward COVID-19 vaccines had lower acceptability of the vaccine due to concerns on long-term side effects, lack of transparent information about the vaccine, and vaccine hesitancy [41, 42]. In order to improve individual’s attitudes toward COVID-19 vaccines, healthcare professions need to 1) understand individuals’ health concerns; 2) provide reliable information related to side effects of the vaccines; and 3) foster strong partnerships with local health departments [42, 43].

Surprisingly, our study found that international students with higher intentions had lowed odds of being fully vaccinated. This unexpected result occurred may be because in our study, 81.2% of international students were already fully vaccinated and they did not need any intentions to receive the vaccine. In addition, the study data are cross-sectional, so results could not imply any causal relationships between interventions and vaccination behavior. Given that even individuals with higher intentions to vaccinate, they may not get vaccinated ultimately because of vaccine hesitancy [44]. Intentions to vaccinate is a critical determinant of COVID-vaccine uptake and can be influenced by personality traits, individuals’ perception of the vaccine, individuals’ trust in the government, individuals’ perceived vulnerability to the disease, and their conscientiousness and demographical background [4548]. It is important to study the moderators of the intention-behavior gap to increase vaccine uptake.

TPB-based factors and intentions to receive a COVID-19 booster

For all students, individuals’ attitudes, subjective norms, and intentions to receive COVID-19 vaccine were significantly associated with their intentions to receive a booster. The TPB framework maintains that PBC is vital to understanding behavior. However, in our study, it was not a significant factor related to intentions to receive a COVID-19 booster for either domestic or international students. One reason is the small percentages of students receiving a booster when the study was conducted: eight international and no domestic students received the booster.

Students’ subjective norms (e.g., perceived social pressure) can shape their behavioral intentions and subsequent decisions about whether to engage in a behavior [30]. For instance, students’ friends, family members, and colleagues could inspire them to get a vaccine. In our study, the subjective norms of COVID-19 vaccination were significantly related to students’ intentions (i.e., among international students and the combined student population) to receive a COVID-19 booster. International students were more likely to say that most people they knew and most of their family and friends would like them to receive COVID-19 vaccines and a booster. International students’ subjective norms may have been also more pronounced than domestic students’ due to the CDC vaccine mandate. Family members of international students and university offices for international students and scholars may encourage these students to receive COVID-19 vaccines to be able to enter the U.S. for school.

Intentions to receive COVID-19 vaccines were significantly correlated with the intentions to receive a COVID-19 booster among all students. International students showed greater intentions than domestic students to be vaccinated and boosted. The largest β value in the combined student population was tied to behavioral intentions (0.61), underscoring the importance of this construct. Even though immunization reduces the spread of COVID-19, its effectiveness depends on individuals’ willingness to receive the vaccine [37, 48]. Webb and Sheeran stated in a meta-analysis that health-related intentions are causally associated with respective health-related behaviors [49]. Ajzen cited intentions as the most critical factor influencing actual behavior [36]. Unsurprisingly, if intentions are excessively low in either the general population or the student population, then the possibility of halting the COVID-19 pandemic drastically declines.

Limitation

This study has several limitations. International students were recruited from a single higher education institution due to limited access during the pandemic, which constrains our findings’ generalizability. Additionally, data were acquired in October 2021, when many colleges did not require a COVID-19 booster. Even though eight international students had received a booster, we did not have sufficient uptake data to analyze. Study data were also gathered via a self-report survey hosted on Qualtrics. Social desirability bias and students’ personal beliefs may have influenced their responses. The cross-sectional nature of the study limits the inferences on causal relationships between TPB constructs and behavior. A more rigorous longitudinal study design is recommended to further evaluate the effects of TPB constructs on vaccination behavior and the relative contributions of each individual construct.

Conclusions

Our study aimed to understand whether TPB-based psychosocial factors (i.e., attitudes, PBC, subjective norms, and behavioral intentions) were related to full COVID-19 vaccination status and the intentions to receive a booster among international and domestic college students in the U.S. PBC was a significant factor related to the full vaccination status among domestic college students, while attitudes were a significant factor associated with all students’ full vaccination status. Moreover, attitudes towards receiving a COVID-19 booster, subjective norms, and intentions to receive COVID-19 vaccines were significantly correlated with the intentions to receive a booster. From a theoretical perspective, our findings somewhat support that the TPB is an applicable framework for explaining COVID-19 vaccination intentions and behavior among both domestic and international college students. Thus, public awareness and educational programs aimed at promoting vaccine acceptance should consider using TPB as a framework and tailor to each group. To enhance uptake of COVID-19 vaccines and boosters and to reduce the incidence of severe cases, healthcare providers and educators can develop vaccine campaigns to promote COVID-19 vaccination among college students. For example, universities and colleges can provide bilingual health interpreters, implement campus-based marketing strategies, send reminders using social media, and offer free and affordable vaccines to increase vaccination rates among international students [50]. When promoting the vaccination rate of domestic students, healthcare providers and educators need to understand students’ health concerns and answer their questions with evidence to increase their PBC [17]. We believe that the COVID-19 vaccine mandate has been crucial to increasing international students’ COVID-19 vaccination rates. Higher education professionals and policymakers should thus reconsider college immunization requirements to improve vaccination rates.

Supporting information

S1 Data set

(XLS)

Acknowledgments

We would like to thank the research participants who gave their valuable time of completing the study. Special thanks to Dr. Catalano and her research team for providing us permission for utilizing the instrument in our study.

Data Availability

All relevant data are within the paper and its Supporting Information files.

Funding Statement

The authors would like to thank the Sherwood foundation (RN031103—LIUSF) who provided research funding to help us focus on the vaccination status among international and domestic students in the United States. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.World Health Organization. WHO Coronavirus (COVID-19) Dashboard. (2022). Available online at https://covid19.who.int/ (Accessed April 24, 2023). [Google Scholar]
  • 2.Centers for Disease Control and Prevention. Vaccines for COVID-19. (May 17, 2022). Available online at https://www.cdc.gov/coronavirus/2019-ncov/vaccines/index.html (Accessed July 31, 2022). [Google Scholar]
  • 3.Centers for Disease Control and Prevention. Benefits of getting a COVID-19 vaccine. (July 13, 2022). Available online at https://www.cdc.gov/coronavirus/2019-ncov/vaccines/vaccine-benefits.html (Accessed August 2, 2022). [Google Scholar]
  • 4.Kecojevic A, Basch CH, Sullivan M. COVID-19 Vaccination and Intention to Vaccinate Among a Sample of College Students in New Jersey. J Community Health. 2021; 46:1059–1068. doi: 10.1007/s10900-021-00992-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Sharma M, Davis RE, Wilkerson AH. COVID-19 Vaccine Acceptance among College Students: A Theory-Based Analysis. Int J Environ Res Public Health. 2021; 18(9):4617. doi: 10.3390/ijerph18094617 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Wotring AJ, Hutchins M, Johnson MK. Ferng SF, Strawser C, Pfrank H, et al. COVID-19 Vaccine Uptake Among College Students at a Midwest University. J Community Health. 2022; 47:292–297. doi: 10.1007/s10900-021-01051-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Hanson M. College Enrollment and Student Demographic Statistics. (July 26, 2022). Available online at https://educationdata.org/college-enrollment-statistics (Accessed August 3, 2022). [Google Scholar]
  • 8.Deng H, Seeling M, Sun LY. Understanding Chinese international students’ perception of flu vaccination on U.S. college campuses. J of Am Coll Health. 2022; Jul 26:1–9. doi: 10.1080/07448481.2022.2103381 [DOI] [PubMed] [Google Scholar]
  • 9.Daly L, Halon A, Aronowitz T, Ross G. A university health initiative toincrease human papillomavirus vaccination rates. J. Nurse Pract. 2016; 12(6):e281–286. [Google Scholar]
  • 10.Ritchie H, Mathieu E, Rodes-Guirao L, Appel C, Giattino C, Ortiz-Ospina E, et al. Coronavirus pandemic (COVID-19). 2020; http://ourworldindata.org/coronavirus [Google Scholar]
  • 11.Mallapaty S. China’s COVID vaccines have been crucial—now immunity is waning. Nature 2021; 598:398–399. doi: 10.1038/d41586-021-02796-w [DOI] [PubMed] [Google Scholar]
  • 12.Moore A, Millar C, Moore E. Meningococcal ACWY vaccine uptake and awareness among student freshers enrolled at Northern Ireland universities. Int J Adolesc Med Health. 2016017; 32(1):0087. doi: 10.1515/ijamh-2016-0087 [DOI] [PubMed] [Google Scholar]
  • 13.Centers for Disease Control and Prevention. Stay Up to Date with COVID-19 Vaccines Including Boosters. (September 8, 2022). Available online at https://www.cdc.gov/coronavirus/2019-ncov/vaccines/index.html (Accessed September 14, 2022). [Google Scholar]
  • 14.Ajzen I. From Intentions to Action: A Theory of Planned Behavior. In: Kuhl J. and Beckmann J., Eds., Action-Control: From Cognition to Behavior, Springer-Verlag, Heidelberg. 1985; 11–39. 10.1007/978-3-642-69746-3_2 [DOI] [Google Scholar]
  • 15.Wu AMS, Lau JTF, Ma YL, Cheng KM, Lau MMC. A longitudinal study using parental cognitions based on the theory of planned behavior to predict childhood influenza vaccination. J. Infect. Public Health. 2020; 13(7):970–79. doi: 10.1016/j.jiph.2020.04.009 [DOI] [PubMed] [Google Scholar]
  • 16.Catalano HP, Knowlden AP, Birch DA. Using the Theory of Planned Behavior to predict HPV vaccination intentions of college men. J Am Coll Health. 2017; 65(3):197–207. doi: 10.1080/07448481.2016.1269771 [DOI] [PubMed] [Google Scholar]
  • 17.Limbu YB, Gautam RK, Zhou W. Predicting Vaccination Intention against COVID-19 Using Theory of Planned Behavior: A Systematic Review and Meta-Analysis. Vaccines. 2022; 10:2026. doi: 10.3390/vaccines10122026 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Chen H, Cohen P, Chen S. How big is a big odds ratio? Interpreting the magnitudes of odds ratios in epidemiological studies. Commun. Stat. 2010; 39:860–864. [Google Scholar]
  • 19.Stevens J., 1996. Applied Multivariate Statistics for the Social Science. Lawrence Erlbaum Associates, New Jersey. [Google Scholar]
  • 20.Kaiser H.F., 1974. An index of factorial simplicity. Psychometrika 39, 31–36. [Google Scholar]
  • 21.Vallée A, Fourn E, Majerholc C, Touche P, Zucman D. COVID-19 Vaccine Hesitancy among French People Living with HIV. Vaccine. (2021) 9,302. doi: 10.3390/vaccines9040302 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Rakusa M, Öztürk S, Moro E. the European Academy of Neurology NeuroCOVID-19 Task Force. COVID-19 vaccination hesitancy among people with chronic neurological disorders: A position paper. Eur J Neurol. (2022) 29:2163– 2172. doi: 10.1111/ene.15368 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Centers for Disease Control and Prevention. People with certain medical conditions. (May 2, 2022.).Available online at https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/people-with-medical-conditions.html (Accessed July 19, 2022). [Google Scholar]
  • 24.Centers for Disease Control and Prevention. Requirement for Proof of COVID-19 Vaccination for Air Passengers. (June 13, 2022). Available online at https://www.cdc.gov/coronavirus/2019-ncov/travelers/proof-of-vaccination.html#:~:text=Do%20I%20still%20need%20proof,proof%20of%20COVID%2D19%20vaccination (Accessed June 17, 2022). [Google Scholar]
  • 25.The White House. National COVID-19 Preparedness Plan. (November 8, 2021). Available at https://www.whitehouse.gov/covidplan/ (Assessed June 19, 2022). [Google Scholar]
  • 26.The Sex, gender, and COVID-19 project. The COVID-19 sex-disaggregated data tracker. (June 13, 2022). Available online at https://globalhealth5050.org/the-sex-gender-and-covid-19-project/the-data-tracker/?explore=country&country=USA#search (Accessed August 12, 2022).
  • 27.Centers for Disease Control and Prevention. COVID-19 Vaccination Coverage and Vaccine Confidence by Sexual Orientation and Gender Identity—United States, August 29–October 30, 2021. (February 4, 2022). Available online at https://www.cdc.gov/mmwr/volumes/71/wr/pdfs/mm7105a3-H.pdf (Accessed August 10, 2022). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Zintel S, Flock C, Arbogast AL, Forster A, von Wagner C, Sieverding M. Gender differences in the intention to get vaccinated against COVID-19: a systematic review and meta-analysis. Z Gesundh Wiss. (2022) doi: 10.1007/s10389-021-01677-w [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Zhong Y, Zhao H, Wang X, Ji J. Using the theory of planned behaviour to explain junior nurses’ and final-year student nurses’ intention to care for COVID-19 patients in China: A multisite cross-sectional study. J Nurs Manag. (2022) 17: doi: 10.1111/jonm.13639 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Clift AK, von Ende A, Tan PS. Smoking and COVID-19 outcomes: an observational and Mendelian randomization study using the UK Biobank cohort. Thorax. 2022; 77:65–73. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Lowe KE, Zein J, Hatipoğlu U, Attaway A. Association of Smoking and Cumulative Pack-Year Exposure With COVID-19 Outcomes in the Cleveland Clinic COVID-19 Registry. JAMA Intern Med. 2021; 181:709–711. doi: 10.1001/jamainternmed.2020.8360 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Nguyen KH, Irvine S, Epstein R, Allen JD, Corlin L. Prior COVID-19 Infection, Mental Health, Food and Financial Insecurity, and Association With COVID-19 Vaccination Coverage and Intent Among College-Aged Young Adults, US, 2021. Prev Chronic Dis 2021;18:210260. doi: 10.5888/pcd18.210260 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Baack BN, Abad N, Yankey D, Kahn KE, Razzaghi H, Brookmeyer K, et al. COVID-19 vaccination coverage and intent among adults aged 18–39 years–United States, March-May 2021. MMWR Morb Mortal Wkly Rep 2021; 70(25):928–933. doi: 10.15585/mmwr.mm7025e2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Centers for Disease Control and Prevention. People with certain medical conditions. (May 2, 2022.).Available online at https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/people-with-medical-conditions.html (Accessed July 19, 2022). [Google Scholar]
  • 35.Poehling MA, Blocker J, Ip EH, Peters TR, Wolfson M. 2009–2010 Seasonal Influenza Vaccination Coverage Among College Students From 8 Universities in North Carolina. Journal of American College Health. 2012; 60(8):541–547. http://10.1080/07448481.2012.700973 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Ajzen I. Perceived behavioral control, self-efficacy, locus of control, and the theory of planned behavior. J. Appl. Soc. Psychol. 2002; 32:665–683. [Google Scholar]
  • 37.Britt RK, Hatten KN, Chappuis SO. Perceived behavioral control, intention to get vaccinated, and usage of online information about the human papillomavirus vaccine. Health Psychol Behav Med. 2014. Jan 1;2(1):52–65. doi: 10.1080/21642850.2013.869175 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Hayashi Y, Romanowich P, Hantula DA. Predicting Intention to Take a COVID-19 Vaccine in the United States: Application and Extension of Theory of Planned Behavior. Am. J. Health Promot. 2022;36(4):710–713. doi: 10.1177/08901171211062584 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Wicaksana B, Yunihastuti E, Shatri H, Pelupessy DC, Koesnoe S, Djauzi S, et al. Predicting Intention to Receive COVID-19 Vaccination in People Living with HIV using an Integrated Behavior Model. Vaccines. 2023; 11(2):296. doi: 10.3390/vaccines11020296 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Greyling T, Rossouw S (2022) Positive attitudes towards COVID-19 vaccines: A crosscountry analysis. PLoS ONE 17(3): e0264994. doi: 10.1371/journal.pone.0264994 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Asres F, Umeta B. COVID-19 vaccines: awareness, attitude and acceptance among undergraduate University students. J of Pharm Policy and Pract. 2022; 15;32. doi: 10.1186/s40545-021-00397-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Brand CO, Stafford T. Using dialogues to increase positive attitudes towards COVID-19 vaccines in a vaccine-hesitant UK population. R. Soc. Open Sci. 2022; 9: 220366. doi: 10.1098/rsos.220366 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Centers for Disease Control and Prevention. Ways Health Departments Can Help Increase COVID-19 Vaccinations. (June 17, 2022). Available online at https://www.cdc.gov/vaccines/covid-19/health-departments/generate-vaccinations.html#:~:text=Work%20with%20existing%20programs%20that,government%20or%20health%20department%20sources. (Accessed August 3, 2023). [Google Scholar]
  • 44.Holtkamp N, Marus J, Ross T. Trends in COVID-19 Vaccination Intentions. Office of the Assistant Secretary for Planning and Evaluation. (April 5, 2022). Available online at https://aspe.hhs.gov/reports/trends-covid-19-vaccination-intentions. (Assess August 3, 2023). [Google Scholar]
  • 45.Khosravi M. Perceived risk of COVID-19 pandemic: The role of public worry and trust. Electron J Gen Med. 2020;17:1–2. http://10.29333/ejgm/7856 [Google Scholar]
  • 46.Li H. To vaccinate or not: The relationship between conscientiousness and individual attitudes toward vaccination in real-life contexts. Scand J Psychol. 2022; 63(4):376–382. doi: 10.1111/sjop.12816 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Wu TY, Ford O, Rainville AJ, Yang X, Chow CM, Lally S, et al. Perceptions of COVID-19 Vaccine, Racism, and Social Vulnerability: An Examination among East Asian Americans, Southeast Asian Americans, South Asian Americans, and Others. Vaccines. 2022; 10:1333. doi: 10.3390/vaccines10081333 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Xiao X, Wong RM. Vaccine hesitancy and perceived behavioral control: a meta-analysis. Vaccine. 2020; 38(33):5131–38. doi: 10.1016/j.vaccine.2020.04.076 [DOI] [PubMed] [Google Scholar]
  • 49.Webb TL, Sheeran P. Does changing behavioral intentions engender behavior change? A meta-analysis of the experimental evidence. Psychol Bull. 2006. Mar;132(2):249–68. doi: 10.1037/0033-2909.132.2.249 [DOI] [PubMed] [Google Scholar]
  • 50.Liu CH, Ling J, Liu C, Schrader K, Ammigan R, Mclntire E. Vaccination rates among international students: Insights from a university health vaccination initiative. Journal of American College Health. 2023; Jan 3:1–8. doi: 10.1080/07448481.2022.2155470 [DOI] [PubMed] [Google Scholar]

Decision Letter 0

Le An Pham

30 Jun 2023

PONE-D-23-12951Using Theory of Planned Behavior to Determine COVID-19 Vaccination Intention and Behavior among International and Domestic College Students in the United StatesPLOS ONE

Dear Dr. liu,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Aug 14 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Le An Pham, Ph.D,MD

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match. 

When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section.

3. Thank you for stating the following in the Acknowledgments Section of your manuscript: 

"We would like to thank the Sherwood foundation (RN031103—LIUSF) who provided research funding to help us focus on the vaccination status among international and domestic students in the United States.."

We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. 

Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: 

"no"

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

4. Thank you for stating the following financial disclosure: "No"

Please state what role the funders took in the study.  If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." 

If this statement is not correct you must amend it as needed. 

Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf.

5. Thank you for stating the following in your Competing Interests section: "no"

Please complete your Competing Interests on the online submission form to state any Competing Interests. If you have no competing interests, please state "The authors have declared that no competing interests exist.", as detailed online in our guide for authors at http://journals.plos.org/plosone/s/submit-now 

This information should be included in your cover letter; we will change the online submission form on your behalf.

6. Please note that in order to use the direct billing option the corresponding author must be affiliated with the chosen institute. Please either amend your manuscript to change the affiliation or corresponding author, or email us at plosone@plos.org with a request to remove this option.

7. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability.

Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized.

Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access.

We will update your Data Availability statement to reflect the information you provide in your cover letter.

8. Please amend either the title on the online submission form (via Edit Submission) or the title in the manuscript so that they are identical.

9. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. 

Additional Editor Comments:

PBC abbreviate for what in abstract?

Please explain that why author use median of the four TPB factors for making the cutoff that divide respondents into low- and high-scoring groups.?

Please have clear definition of variables that combine some criteria such as chronic diseases, smoking, finance…and also table 2 intended vaccination COVID 19, intended to take booster (tables 2: Received 1 dose; Fully vaccinated; Received booster) that make confuse..

Please report the result of OR with 95% CI

Please explain clear about “Domestic students who were male (OR: 3.22, p = .001) and had lower PBC (OR: 8.33, p = .049) had lower odds of being fully vaccinated?”

Please explain that why author use determinant instead of risk for OR?

Please Explain that TBP model is appropriate to measure intended to take booster Vaccine COVID 19 when R =0.08?? Whether TBP model appropriate to all participants such as LMIC? They familiar with HBM than TBP

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: No

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: No

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: 4. Conclusions are presented in an appropriate fashion and are supported by the data.

Conclusions are presented in a clear outline of 2 sections pertaining to the summary of the findings and implications for health interventions. However, there are still places for improvement. The conclusion only presented a part of the results through the wrap-up of associated factors with vaccination only among domestic college students and all students. Those findings relating to international students should be summarized and key differences between 2 groups should be highlighted. Based on this, the author might emphasize the need for health interventions that are exclusive for each group. Such practical implications will provide more actionable insights for policymakers, healthcare professionals, and educators.

5. The article is presented in an intelligible fashion and is written in standard English.

Although the study utilizes a robust methodology that yields important and relevant findings, the presentation of the discussion lacks clarity and coherence. The discussion elaborates the relationship between psychosocial elements of the TPB (i.e., attitude, behavioral intention, perceived behavioral control, and subjective norms) and full COVID-19 vaccination, as well as intentions to receive a booster, in both domestic and international students. However, the information pertaining to the associated factors with full vaccination or the booster is intertwined throughout the discussion, making it difficult to distinguish between them. Similarly, the information describing the determinants among domestic and international students is mixed within paragraphs, hindering the viewers' ability to discern the key differences. Seemingly, determinants of full Covid-19 vaccination among domestic students include PBC, chronic illnesses and smoking. Regarding the reception of boosters in domestic students, the intention to receive the COVID-19 vaccine predicts the intention to receive the booster. However, viewers might have difficulty identifying associated factors as these pieces of information were scattered throughout the discussion. Furthermore, there is repetition of certain points in discussion, further impeding its clarity and coherence. Several repeated points and their location are listed below:

Paragraph 1: International students COVID-19 vaccination rates were significantly higher than for domestic students. Later in paragraph 1: More international students (81.2%) than domestic students (55%) in our sample had already received COVID-19 vaccines

Paragraph 5: PBC significantly predicted domestic students’ full vaccination, reflecting confidence in their ability to be vaccinated against COVID-19. Paragraph 9: PBC was the sole TPB variable to significantly predict vaccination against COVID-19 among domestic students and the combined student sample in this study.

To enhance the clarity and cohesiveness of the discussion, I suggest a thorough rewrite in which a clear outline of TBP associated factors and primary determinants of full covid-19 vaccination as well as booster acceptance should be provided in 2 separate sections dedicating to international and domestic students. To improve the overall readability of the discussion, the author should avoid repetition and unnecessary redundancy.

Reviewer #2: The author should clarify the methodology of study especially an TPB-based instrument development.

This finding has helped health managers more information to develop health policies to prevent Covid-19 infection.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: PLOS ONE_reviewer.doc

Attachment

Submitted filename: Review- PONE-D-23-12951.pdf

PLoS One. 2024 Feb 2;19(2):e0293130. doi: 10.1371/journal.pone.0293130.r002

Author response to Decision Letter 0


18 Aug 2023

Dear reviews,

Thank you so much for all the points you have addressed. We have revised our manuscript to address all the points. We re-did the data analysis and Discussion to enhance clarity of the manuscript. We uploaded a document with fully explanations. Please see "Responses to the reviewers comments." Please let us know if there is anything we can do it better.

Many thanks.

Attachment

Submitted filename: Responses to reviewers comments HL 8.7.2023.docx

Decision Letter 1

Khalid Mehmood

6 Oct 2023

Using the Theory of Planned Behavior to determine COVID-19 vaccination intentions and behavior among international and domestic college students in the United States

PONE-D-23-12951R1

Dear Dr. liu,

We are pleased to inform you that your manuscript, "Using the Theory of Planned Behavior to determine COVID-19 vaccination intentions and behavior among international and domestic college students in the United States," has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Congratulations! 

In closing, thank you very much again for working with us to bring this work to fruition. We hope that as a member of the PLOS ONE community, you will continue to help the journal as a reviewer, use our articles (including your own) as a source of citation in your future work, and continue to submit your best work on PLOS ONE. In particular, please do try to cite the most recent of the published articles in PLOS ONE.

Congratulations again, and thank you for your contribution to PLOS ONE!

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Khalid Mehmood

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: (No Response)

Reviewer #2: The authors have addressed my comments in the revised manuscript, including the theoretical framework, methods and materials, results, discussion, and appendix. Particularly, they have thoroughly revised the entire discussion section and added sub-headings to enhance the manuscript's clarity, as I initially suggested.

Furthermore, the authors have made substantial improvements to both the structure and methodology of the manuscript based on the feedback received from the reviewers. In my opinion, the manuscript is now ready for acceptance. I hope that the authors will provide the required ethics statement and meet the Plos One journal's requirements to ensure that the manuscript can be published in the future.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Pham Duong Uyen Binh

Reviewer #2: No

**********

Attachment

Submitted filename: PONE reviewer2_phamduonguyenbinh.docx

Acceptance letter

Khalid Mehmood

13 Oct 2023

PONE-D-23-12951R1

Using the Theory of Planned Behavior to determine COVID-19 vaccination intentions and behavior among international and domestic college students in the United States

Dear Dr. Liu:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Prof. Dr. Khalid Mehmood

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Data set

    (XLS)

    Attachment

    Submitted filename: PLOS ONE_reviewer.doc

    Attachment

    Submitted filename: Review- PONE-D-23-12951.pdf

    Attachment

    Submitted filename: Responses to reviewers comments HL 8.7.2023.docx

    Attachment

    Submitted filename: PONE reviewer2_phamduonguyenbinh.docx

    Data Availability Statement

    All relevant data are within the paper and its Supporting Information files.


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES